 | • レポートコード：MRC2-11QY03921 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は壊死性腸炎のグローバル市場について調査・分析したレポートです。種類別（ステージI、ステージII、ステージIII）市場規模、用途別（病院・診療所、外来外科センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別壊死性腸炎の競争状況、市場シェア ・世界の壊死性腸炎市場：種類別市場規模 2015年-2020年（ステージI、ステージII、ステージIII） ・世界の壊死性腸炎市場：種類別市場規模予測 2021年-2026年（ステージI、ステージII、ステージIII） ・世界の壊死性腸炎市場：用途別市場規模 2015年-2020年（病院・診療所、外来外科センター、診断センター） ・世界の壊死性腸炎市場：用途別市場規模予測 2021年-2026年（病院・診療所、外来外科センター、診断センター） ・北米の壊死性腸炎市場分析：米国、カナダ ・ヨーロッパの壊死性腸炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの壊死性腸炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の壊死性腸炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの壊死性腸炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Pfizer、Eli Lilly And Company、Bayer HealthCare、Becton, Dickinson And Company、Bristol-Myers Squibb Company、Medtronic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.
Market Analysis and Insights: Global Necrotising Enterocolitis Market
The global Necrotising Enterocolitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Necrotising Enterocolitis Scope and Market Size
Necrotising Enterocolitis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Necrotising Enterocolitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Pfizer
Eli Lilly And Company
Bayer HealthCare
Becton, Dickinson And Company
Bristol-Myers Squibb Company
Medtronic
…
Market segment by Type, the product can be split into
Stage I
Stage II
Stage III
Market segment by Application, split into
Hospitals & Clinics
Ambulatory Surgical Center
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Necrotising Enterocolitis Revenue
1.4 Market by Type
1.4.1 Global Necrotising Enterocolitis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Stage I
1.4.3 Stage II
1.4.4 Stage III
1.5 Market by Application
1.5.1 Global Necrotising Enterocolitis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory Surgical Center
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Necrotising Enterocolitis Market Perspective (2015-2026)
2.2 Global Necrotising Enterocolitis Growth Trends by Regions
2.2.1 Necrotising Enterocolitis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Necrotising Enterocolitis Historic Market Share by Regions (2015-2020)
2.2.3 Necrotising Enterocolitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Necrotising Enterocolitis Market Growth Strategy
2.3.6 Primary Interviews with Key Necrotising Enterocolitis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Necrotising Enterocolitis Players by Market Size
3.1.1 Global Top Necrotising Enterocolitis Players by Revenue (2015-2020)
3.1.2 Global Necrotising Enterocolitis Revenue Market Share by Players (2015-2020)
3.1.3 Global Necrotising Enterocolitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Necrotising Enterocolitis Market Concentration Ratio
3.2.1 Global Necrotising Enterocolitis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Necrotising Enterocolitis Revenue in 2019
3.3 Necrotising Enterocolitis Key Players Head office and Area Served
3.4 Key Players Necrotising Enterocolitis Product Solution and Service
3.5 Date of Enter into Necrotising Enterocolitis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Necrotising Enterocolitis Historic Market Size by Type (2015-2020)
4.2 Global Necrotising Enterocolitis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Necrotising Enterocolitis Market Size by Application (2015-2020)
5.2 Global Necrotising Enterocolitis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Necrotising Enterocolitis Market Size (2015-2020)
6.2 Necrotising Enterocolitis Key Players in North America (2019-2020)
6.3 North America Necrotising Enterocolitis Market Size by Type (2015-2020)
6.4 North America Necrotising Enterocolitis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Necrotising Enterocolitis Market Size (2015-2020)
7.2 Necrotising Enterocolitis Key Players in Europe (2019-2020)
7.3 Europe Necrotising Enterocolitis Market Size by Type (2015-2020)
7.4 Europe Necrotising Enterocolitis Market Size by Application (2015-2020)
8 China
8.1 China Necrotising Enterocolitis Market Size (2015-2020)
8.2 Necrotising Enterocolitis Key Players in China (2019-2020)
8.3 China Necrotising Enterocolitis Market Size by Type (2015-2020)
8.4 China Necrotising Enterocolitis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Necrotising Enterocolitis Market Size (2015-2020)
9.2 Necrotising Enterocolitis Key Players in Japan (2019-2020)
9.3 Japan Necrotising Enterocolitis Market Size by Type (2015-2020)
9.4 Japan Necrotising Enterocolitis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Necrotising Enterocolitis Market Size (2015-2020)
10.2 Necrotising Enterocolitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Necrotising Enterocolitis Market Size by Type (2015-2020)
10.4 Southeast Asia Necrotising Enterocolitis Market Size by Application (2015-2020)
11 India
11.1 India Necrotising Enterocolitis Market Size (2015-2020)
11.2 Necrotising Enterocolitis Key Players in India (2019-2020)
11.3 India Necrotising Enterocolitis Market Size by Type (2015-2020)
11.4 India Necrotising Enterocolitis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Necrotising Enterocolitis Market Size (2015-2020)
12.2 Necrotising Enterocolitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Necrotising Enterocolitis Market Size by Type (2015-2020)
12.4 Central & South America Necrotising Enterocolitis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Necrotising Enterocolitis Introduction
13.1.4 GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Necrotising Enterocolitis Introduction
13.2.4 Pfizer Revenue in Necrotising Enterocolitis Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Eli Lilly And Company
13.3.1 Eli Lilly And Company Company Details
13.3.2 Eli Lilly And Company Business Overview
13.3.3 Eli Lilly And Company Necrotising Enterocolitis Introduction
13.3.4 Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2015-2020)
13.3.5 Eli Lilly And Company Recent Development
13.4 Bayer HealthCare
13.4.1 Bayer HealthCare Company Details
13.4.2 Bayer HealthCare Business Overview
13.4.3 Bayer HealthCare Necrotising Enterocolitis Introduction
13.4.4 Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2015-2020)
13.4.5 Bayer HealthCare Recent Development
13.5 Becton, Dickinson And Company
13.5.1 Becton, Dickinson And Company Company Details
13.5.2 Becton, Dickinson And Company Business Overview
13.5.3 Becton, Dickinson And Company Necrotising Enterocolitis Introduction
13.5.4 Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2015-2020)
13.5.5 Becton, Dickinson And Company Recent Development
13.6 Bristol-Myers Squibb Company
13.6.1 Bristol-Myers Squibb Company Company Details
13.6.2 Bristol-Myers Squibb Company Business Overview
13.6.3 Bristol-Myers Squibb Company Necrotising Enterocolitis Introduction
13.6.4 Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2015-2020)
13.6.5 Bristol-Myers Squibb Company Recent Development
13.7 Medtronic
13.7.1 Medtronic Company Details
13.7.2 Medtronic Business Overview
13.7.3 Medtronic Necrotising Enterocolitis Introduction
13.7.4 Medtronic Revenue in Necrotising Enterocolitis Business (2015-2020)
13.7.5 Medtronic Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Necrotising Enterocolitis Key Market Segments
Table 2. Key Players Covered: Ranking by Necrotising Enterocolitis Revenue
Table 3. Ranking of Global Top Necrotising Enterocolitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Necrotising Enterocolitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stage I
Table 6. Key Players of Stage II
Table 7. Key Players of Stage III
Table 8. Global Necrotising Enterocolitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Necrotising Enterocolitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Necrotising Enterocolitis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Necrotising Enterocolitis Market Share by Regions (2015-2020)
Table 12. Global Necrotising Enterocolitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Necrotising Enterocolitis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Necrotising Enterocolitis Market Growth Strategy
Table 18. Main Points Interviewed from Key Necrotising Enterocolitis Players
Table 19. Global Necrotising Enterocolitis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Necrotising Enterocolitis Market Share by Players (2015-2020)
Table 21. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotising Enterocolitis as of 2019)
Table 22. Global Necrotising Enterocolitis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Necrotising Enterocolitis Product Solution and Service
Table 25. Date of Enter into Necrotising Enterocolitis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Necrotising Enterocolitis Market Size Share by Type (2015-2020)
Table 29. Global Necrotising Enterocolitis Revenue Market Share by Type (2021-2026)
Table 30. Global Necrotising Enterocolitis Market Size Share by Application (2015-2020)
Table 31. Global Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Necrotising Enterocolitis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 35. North America Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 37. North America Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 39. Europe Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 41. Europe Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 43. Europe Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 45. China Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 47. China Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 48. China Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 49. China Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 50. China Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 51. Japan Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 53. Japan Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 55. Japan Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 59. Southeast Asia Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 61. Southeast Asia Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 63. India Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 65. India Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 66. India Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 67. India Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 68. India Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Necrotising Enterocolitis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Necrotising Enterocolitis Market Share (2019-2020)
Table 71. Central & South America Necrotising Enterocolitis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Necrotising Enterocolitis Market Share by Type (2015-2020)
Table 73. Central & South America Necrotising Enterocolitis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Necrotising Enterocolitis Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Eli Lilly And Company Company Details
Table 86. Eli Lilly And Company Business Overview
Table 87. Eli Lilly And Company Product
Table 88. Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 89. Eli Lilly And Company Recent Development
Table 90. Bayer HealthCare Company Details
Table 91. Bayer HealthCare Business Overview
Table 92. Bayer HealthCare Product
Table 93. Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 94. Bayer HealthCare Recent Development
Table 95. Becton, Dickinson And Company Company Details
Table 96. Becton, Dickinson And Company Business Overview
Table 97. Becton, Dickinson And Company Product
Table 98. Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 99. Becton, Dickinson And Company Recent Development
Table 100. Bristol-Myers Squibb Company Company Details
Table 101. Bristol-Myers Squibb Company Business Overview
Table 102. Bristol-Myers Squibb Company Product
Table 103. Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 104. Bristol-Myers Squibb Company Recent Development
Table 105. Medtronic Company Details
Table 106. Medtronic Business Overview
Table 107. Medtronic Product
Table 108. Medtronic Revenue in Necrotising Enterocolitis Business (2015-2020) (Million US$)
Table 109. Medtronic Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotising Enterocolitis Market Share by Type: 2020 VS 2026
Figure 2. Stage I Features
Figure 3. Stage II Features
Figure 4. Stage III Features
Figure 5. Global Necrotising Enterocolitis Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Necrotising Enterocolitis Report Years Considered
Figure 10. Global Necrotising Enterocolitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Necrotising Enterocolitis Market Share by Regions: 2020 VS 2026
Figure 12. Global Necrotising Enterocolitis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Necrotising Enterocolitis Market Share by Players in 2019
Figure 15. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotising Enterocolitis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Necrotising Enterocolitis Revenue in 2019
Figure 17. North America Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Necrotising Enterocolitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ステージピアノの世界市場（～2026年） Market Analysis and Insights: Global Stage Pianos Market The global Stage Pianos market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Stage Pianos Scope and Market Size Stage Pianos market is segmented by Type, and by Appli…- 末期腎疾患治療の世界市場（～2026年） Market Analysis and Insights: Global End-Stage Kidney Disease Treatment Market The global End-Stage Kidney Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global End-Stage Kidney Disease Treatment Scope and …
- 末期腎疾患（ESRD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global End-Stage Renal Disease (ESRD) Drugs Market The global End-Stage Renal Disease (ESRD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global End-Stage Renal Disease (ESRD) Drugs Scop…
- 第一段階・第二段階スキューバレギュレーターの世界市場（～2026年） A medium (intermediate) pressure hose is used to carry breathing gas (typically at between 8 and 10 bar above ambient) from the first stage regulator to the second stage, or demand valve, which is held in the mouth by the diver, or attached to the full face mask or diving helmet. Market Analysis and…
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…